MAPT and metabolic disease: Finally, there is a high degree of heterogeneity in AD among patients; the pathogenesis of AD is complex, involving amyloid plaques, Tau protein tangles, neuroinflammation, and metabolic disorders, and a unified pathologic model has yet to be developed.